These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22413798)

  • 21. Primer on estimating withdrawal times after extralabel drug use.
    Riviere JE; Webb AI; Craigmill AL
    J Am Vet Med Assoc; 1998 Oct; 213(7):966-8. PubMed ID: 9776991
    [No Abstract]   [Full Text] [Related]  

  • 22. Veterinary drug bioequivalence determination.
    Toutain PL; Koritz GD
    J Vet Pharmacol Ther; 1997 Apr; 20(2):79-90. PubMed ID: 9131533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of bioequivalence study regulatory requirements for human and veterinary drugs.
    Grabowski T; Marczak M; Jaroszewski JJ; Whitmire M
    Regul Toxicol Pharmacol; 2012 Nov; 64(2):233-42. PubMed ID: 22917973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical challenges in veterinary product development.
    Ahmed I; Kasraian K
    Adv Drug Deliv Rev; 2002 Oct; 54(6):871-82. PubMed ID: 12363436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained release veterinary parenteral products.
    Medlicott NJ; Waldron NA; Foster TP
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1345-65. PubMed ID: 15191786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thoughts on the benefits of personalized medicine.
    Greek J; Greek R
    J Am Vet Med Assoc; 2009 Jan; 234(1):40. PubMed ID: 19119962
    [No Abstract]   [Full Text] [Related]  

  • 27. Introduction to the bioequivalence theme issue.
    Martinez MN; Hunter RP
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():1-2. PubMed ID: 22413785
    [No Abstract]   [Full Text] [Related]  

  • 28. [Can we just inject without needles?].
    Eussen B
    Tijdschr Diergeneeskd; 2010 Apr; 135(7):294. PubMed ID: 20415033
    [No Abstract]   [Full Text] [Related]  

  • 29. Demonstrating bioequivalence using clinical endpoint studies.
    Bermingham E; Del Castillo JR; Lainesse C; Pasloske K; Radecki S
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():31-7. PubMed ID: 22413789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Waiting times for veterinary drugs in guidelines disappears].
    de Groot SJ
    Tijdschr Diergeneeskd; 2003 Nov; 128(21):662-3. PubMed ID: 14650726
    [No Abstract]   [Full Text] [Related]  

  • 31. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and opportunities in polymer technology applied to veterinary medicine.
    Bermudez JM; Cid AG; Ramírez-Rigo MV; Quinteros D; Simonazzi A; Sánchez Bruni S; Palma S
    J Vet Pharmacol Ther; 2014 Apr; 37(2):105-24. PubMed ID: 23980692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applying pharmacokinetics to veterinary clinical practice.
    Trepanier LA
    Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1013-26. PubMed ID: 23890235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA/CVM's Compliance Policy Guide on compounding of drugs.
    J Am Vet Med Assoc; 1996 Dec; 209(12):2025-9. PubMed ID: 8960175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concepts and issues with interspecies scaling in zoological pharmacology.
    Hunter RP; Isaza R
    J Zoo Wildl Med; 2008 Dec; 39(4):517-26. PubMed ID: 19110691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
    Lees P; Landoni MF; Giraudel J; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The scientific basis for establishing solubility criteria for veterinary species.
    Martinez MN; Fahmy R
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():81-6. PubMed ID: 22413794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing product bioequivalence for extended-release formulations and drugs with long half-lives.
    Gehring R; Martinez M
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():3-9. PubMed ID: 22413786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A SAS/IML program for simulating pharmacokinetic data.
    Russek-Cohen E; Martinez MN; Nevius AB
    Comput Methods Programs Biomed; 2005 Apr; 78(1):39-60. PubMed ID: 15780889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges with the development and approval of pharmaceuticals for fish.
    Storey S
    AAPS J; 2005 Sep; 7(2):E335-43. PubMed ID: 16353913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.